Tag: Abivax
Abivax presents its 2023 half-year financial results. – 09/21/2023 at 6:15 p.m.
ABIVAX press release Abivax presents its 2023 half-year financial results. Abivax SA, a clinical-stage biotechnology company focused on developing therapeutic treatments that harness the body’s natural regulatory mechanisms to modulate…
Abivax accentuates its losses in the first half – 09/21/2023 at 6:26 p.m.
(AOF) – Abivax announces that its cash flow as of June 30, 2023 amounts to 114.4 million euros compared to 27.0 million euros at the end of 2022. The biotech…
Abivax: Biotech Abivax displays its American ambitions, shares fall
(BFM Bourse) – The company provided a progress update on Thursday on its operational and commercial activity. The group has indicated that it wants to open an office in the…
Abivax: cash flow of 118 million euros, visibility until mid-2024 – 09/07/2023 at 10:01
(AOF) – Abivax today presents its strategy focused on its preparation for the potential commercialization of its lead drug candidate, obefazimod, in the treatment of IBD (Chronic Inflammatory Bowel Diseases).…
Abivax: the new roadmap is presented – 09/07/2023 at 12:36
(CercleFinance.com) – Abivax unveiled on Thursday a new strategic roadmap focused on preparing for the potential commercialization of its lead drug candidate in the treatment of inflammatory diseases chronic intestinal…
Abivax: Patrick Malloy is appointed Senior Vice-President Investor Relations of Abivax. – 08/23/2023 at 6:15 p.m.
ABIVAX press release Patrick Malloy is appointed Senior Vice President Investor Relations of Abivax. Abivax today announces the appointment of Patrick Malloy as Senior Vice President Investor Relations. Mr. Malloy…
Abivax: in green, a supporting broker
(CercleFinance.com) – Abivax gains more than 1% in Paris, benefiting in particular from a positive analysis by Oddo BHF which confirms its ‘outperformance’ opinion and its target price of 30…
Abivax: two structured financings for 150 million
(CercleFinance.com) – Abivax announces that it has concluded two structured financings for a maximum total amount of 150 million euros (up to 75 million each) after Kreos Capital and Claret…
Abivax announces two financings for a total amount of 150 million euros.
(AOF) – Abivax has concluded two structured financings simultaneously for a maximum total amount of 150 million euros. The specialist in inflammatory diseases specifies that this fundraising includes financing for…
Abivax: two structured financings for 150 million – 08/21/2023 at 10:00 am
(CercleFinance.com) – Abivax announces that it has concluded two structured financings for a maximum total amount of 150 million euros (up to 75 million each) after Kreos Capital and Claret…
Abivax announces two financings for a total amount of 150 million euros. – 08/21/2023 at 10:23
(AOF) – Abivax has concluded two structured financings simultaneously for a maximum total amount of 150 million euros. The specialist in inflammatory diseases specifies that this fundraising includes financing for…
Abivax announces its intention to make a public offering in the United States – 08/10/2023 at 18:18
(AOF) – Abivax announces its intention to make a public offering of its ordinary shares, in the form of “American Depositary Shares (ADS)”, in the United States, subject to market…